The American Journal of Medicine
Volume 119, Issue 7, Supplement 1 , Pages S47-S53 , July 2006

Water and Sodium Retention in Edematous Disorders: Role of Vasopressin and Aldosterone

  • Robert W. Schrier, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Robert W. Schrier, MD, Department of Medicine, The University of Colorado Health Sciences Center, 4200 East Ninth Avenue, B173, Denver, Colorado 80262.

References 

  1. Schrier RW . Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) . N Engl J Med . 1988;319:1065–1072
  2. Schrier RW . Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) . N Engl J Med . 1988;319:1127–1134
  3. Schrier RW . Body fluid volume regulation in health and disease (a unifying hypothesis) . Ann Intern Med . 1990;113:155–159
  4. Schrier RW , Niederberger M . Paradoxes of body fluid volume regulation in health and disease (a unifying hypothesis) . West J Med . 1994;161:393–408
  5. Verney EB . The antidiuretic hormone and the factors which determine its release . Proc R Soc Lond B Biol Sci . 1947;135:25–106
  6. Szatalowicz VL , Arnold PE , Chaimovitz C , Bichet D , Berl T , Schrier RW . Radioimmunoassay of plasma arginine vasopressin hyponatremic patients with congestive heart failure . N Engl J Med . 1981;305:263–266
  7. Bichet D , Szatalowicz V , Chaimovitz C , Schrier RW . Role of vasopressin in abnormal water excretion in cirrhotic patients . Ann Intern Med . 1982;96:413–417
  8. Wang X-Y , Masilamani S , Nielsen J , et al.   The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon . J Clin Invest . 2001;108:215–222
  9. Ecelbarger CA , Nielsen S , Olson BR , et al.   Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat . J Clin Invest . 1997;99:1852–1863
  10. Schrier RW . A unifying hypothesis of body fluid volume regulation (The Lilly Lecture 1992) . J R Coll Physicians Lond . 1992;26:295–306
  11. Schrier RW , Ecder T . Unifying hypothesis of body fluid volume regulation (implications for cardiac failure and cirrhosis) . Mt Sinai J Med . 2001;68:350–361
  12. Schrier RW , Berl T . Nonosmolar factors affecting renal water excretion (first of two parts) . N Engl J Med . 1975;292:81–88
  13. Schrier RW , Berl T . Nonosmolar factors affecting renal water excretion (second of two parts) . N Engl J Med . 1975;292:141–145
  14. Kannan H , Yagi K . Supraoptic neurosecretory neurons (evidence for the existence of converging inputs both from carotid baroreceptors and osmoreceptors) . Brain Res . 1978;145:385–390
  15. Schrier RW , Abraham WT . Hormones and hemodynamics in heart failure . N Engl J Med . 1999;341:577–585
  16. Bichet DG , Van Putten VJ , Schrier RW . Potential role of the increased sympathetic activity in impaired sodium and water excretion in cirrhosis . N Engl J Med . 1982;307:1552–1557
  17. Berl T , Henrich WL , Erickson AL , Schrier RW . Prostaglandins in the beta-adrenergic and baroreceptor-mediated secretion of renin . Am J Physiol . 1979;236:F472–F477
  18. Schrier RW , Briner V , Caramelo C . Cellular action and interactions of arginine vasopressin in vascular smooth muscle (mechanisms and clinical implications) . J Am Soc Nephrol . 1993;4:2–11
  19. Schrier RW , Ohara M , Rogachev B , Xu L , Knotek M . Aquaporin-2 water channels and vasopressin antagonists in edematous disorders . Mol Genet Metab . 1998;65:255–263
  20. Schrier RW , Cadnapaphornchai MA , Ohara M . Water retention and aquaporins in heart failure, liver disease, and pregnancy . J R Soc Med . 2001;94:265–269
  21. Schrier RW , Cadnapaphornchai MA . Renal aquaporin water channels (from molecules to human disease) . Prog Biophys Mol Biol . 2003;81:117–131
  22. Schrier RW , Chen YC , Cadnapaphornchai MA . From finch to fish to man (role of aquaporins in body fluid and brain water regulation) . Neuroscience . 2004;129:897–904
  23. Schrier RW . Role of diminished renal function in cardiovascular mortality (marker or pathogenetic factor?) . J Am Coll Cardiol . 2006;47:1–8
  24. Schrier RW , Better OS . Peripheral arterial vasodilation hypothesis (implications for impaired aldosterone escape) . Eur J Gastroenterol Hepatol . 1991;3:721–729
  25. Pettersson A , Hedner J , Hedner T . Relationship between renal sympathetic activity and diuretic effects of atrial natriuretic peptide (ANP) in the rat . Acta Physiol Scand . 1989;135:323–333
  26. Koepke JP , DiBona GF . Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders . Am J Physiol . 1987;252(pt 2):F865–F871
  27. Abraham WT , Lauwaars ME , Kim JK , Pena RL , Schrier RW . Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis . Hepatology . 1995;22:737–743
  28. Gheorghiade M , Gattis WA , O’Connor CM , et al.  Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators   Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure (a randomized controlled trial) . JAMA . 2004;291:1963–1971
  29. Tsuboi Y , Ishikawa S-E , Fujisawa G , Okada K , Saito T . Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats . Kidney Int . 1994;46:237–244
  30. Martin P-Y , Abraham WT , Xu L , et al.   Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure . J Am Soc Nephrol . 1999;10:2165–2170
  31. Goldsmith S . Is there a cardiovascular rationale for the use of combined vasopressin V1a/V2 receptor antagonists . Am J Med . 2006;119(suppl 7A):S93–S96
  32. Schrier RW , Arroyo V , Bernardi M , Epstein M , Henriksen JH , Rodes J . Peripheral arterial vasodilation hypothesis (a proposal for the initiation of renal sodium and water retention in cirrhosis) . Hepatology . 1988;8:1151–1157
  33. Martin P-Y , Xu DL , Niederberger M , et al.   Upregulation of the endothelial constitutive NOS (a major role in the increased NO production in cirrhotic rats) . Am J Physiol . 1996;270(pt 2):F494–F499
  34. Martin P-Y , Ohara M , Gines P , et al.   Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites . J Clin Invest . 1998;101:235–242
  35. Uriz J , Gines P , Cardenas A , et al.   Terlipressin plus albumin infusion (an effective and safe therapy of hepatorenal syndrome) . J Hepatol . 2000;33:43–48
  36. Sort P , Navasa M , Arroyo V , et al.   Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis . N Engl J Med . 1999;341:403–409
  37. Chapman AB , Abraham WT , Zamudio S , et al.   Temporal relationships between hormonal and hemodynamic changes in early human pregnancy . Kidney Int . 1998;54:2056–2063
  38. Ohara M , Martin P-Y , Xu D-L , et al.   Upregulation of aquaporin-2 water channel expression in pregnant rats . J Clin Invest . 1998;101:1076–1083
  39. Cadnapaphornchai MA , Ohara M , Morris KG , et al.   Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy . Am J Physiol Renal Physiol . 2001;280:F592–F598
  40. Schrier RW , Briner VA . Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy (implication for pathogenesis of preeclampsia-eclampsia) . Obstet Gynecol . 1991;77:632–639
  41. Schrier RW , Cadnapaphornchai MA , Umenishi F . Water-losing and water-retaining states (role of water channels and vasopressin receptor antagonists) . Heart Disease . 2001;3:210–214

 This work was supported by Grant No. P01 DK19928 from the National Institute of Diabetes, Digestive, and Kidney Diseases.

PII: S0002-9343(06)00493-1

doi: 10.1016/j.amjmed.2006.05.007

The American Journal of Medicine
Volume 119, Issue 7, Supplement 1 , Pages S47-S53 , July 2006